C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,000 | +1000.0% | 5,804 | +936.4% | 0.00% | – |
| Q2 2023 | $1,000 | -88.9% | 560 | -80.9% | 0.00% | – |
| Q1 2023 | $9,000 | -81.6% | 2,933 | -64.6% | 0.00% | – |
| Q4 2022 | $49,000 | +444.4% | 8,286 | +683.9% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 1,057 | +35.5% | 0.00% | – |
| Q2 2022 | $6,000 | -90.0% | 780 | -68.2% | 0.00% | – |
| Q1 2022 | $60,000 | -83.7% | 2,456 | -78.6% | 0.00% | – |
| Q4 2021 | $369,000 | +8.2% | 11,475 | +50.5% | 0.00% | – |
| Q3 2021 | $341,000 | +74.0% | 7,625 | +47.3% | 0.00% | – |
| Q2 2021 | $196,000 | +493.9% | 5,177 | +472.0% | 0.00% | – |
| Q1 2021 | $33,000 | -2.9% | 905 | -11.5% | 0.00% | – |
| Q4 2020 | $34,000 | – | 1,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |